600812 華北製藥
按盤價 
6.630 +0.600 (+9.950%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.157 | 3.358 | 2.373 | 0.092 | -12.107 |
| 總資產報酬率 ROA (%) | 0.300 | 0.854 | 0.599 | 0.023 | -2.987 |
| 投入資產回報率 ROIC (%) | 0.370 | 1.046 | 0.726 | 0.028 | -3.593 | 邊際利潤分析 |
| 銷售毛利率 (%) | 27.043 | 31.005 | 31.966 | 31.981 | 33.380 |
| 營業利潤率 (%) | 2.948 | 3.830 | 3.158 | 1.546 | -5.406 |
| 息稅前利潤/營業總收入 (%) | 6.820 | 7.612 | 7.453 | 6.238 | -0.129 |
| 淨利潤/營業總收入 (%) | 2.154 | 2.786 | 2.178 | 0.488 | -6.465 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 64.861 | 79.546 | 86.309 | 48.541 | -33.271 |
| 價值變動淨收益/利潤總額(%) | 25.524 | 16.962 | 14.900 | 29.552 | -7.790 |
| 營業外收支淨額/利潤總額(%) | -0.372 | 0.962 | -0.597 | 1.314 | -0.453 | 償債能力分析 |
| 流動比率 (X) | 0.760 | 0.656 | 0.753 | 0.781 | 0.724 |
| 速動比率 (X) | 0.524 | 0.461 | 0.524 | 0.527 | 0.521 |
| 資產負債率 (%) | 67.495 | 67.815 | 68.914 | 70.079 | 70.650 |
| 帶息債務/全部投入資本 (%) | 66.497 | 66.949 | 67.260 | 67.438 | 67.070 |
| 股東權益/帶息債務 (%) | 48.519 | 47.382 | 45.498 | 45.407 | 45.222 |
| 股東權益/負債合計 (%) | 38.697 | 38.015 | 36.423 | 36.192 | 35.352 |
| 利息保障倍數 (X) | 1.756 | 2.033 | 1.728 | 1.335 | -0.024 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 105.816 | 86.882 | 72.592 | 74.026 | 71.826 |
| 存貨周轉天數 (天) | 142.753 | 138.929 | 137.207 | 134.173 | 126.481 |
| 備註： | 即時報價更新時間為 12/10/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
